Related Experiment Video
Updated: Dec 7, 2025

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
The Compromised Intestinal Barrier Induced by Mycotoxins
Yanan Gao1,2,3,4, Lu Meng1,2,3,4, Huimin Liu1,2,3,4
1Key Laboratory of Quality & Safety Control for Milk and Dairy Products of Ministry of Agriculture and Rural Affairs, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing 100193, China.
Mycotoxins, fungal toxins in food and feed, damage the intestinal barrier. This review details how mycotoxins disrupt physical, chemical, immune, and microbial gut functions, impacting health.
Area of Science:
- Toxicology
- Gastroenterology
- Microbiology
Background:
- Mycotoxins are fungal metabolites contaminating food and feed, posing risks to human and animal health.
- The intestine acts as a primary defense, comprising physical, chemical, immunological, and microbial barriers.
Purpose of the Study:
- To review literature on mycotoxin-induced intestinal barrier dysfunction.
- To elucidate mechanisms of intestinal integrity disruption by mycotoxins.
- To explore the impact of combined mycotoxin exposure.
Main Methods:
- Literature review of in vitro, ex vivo, and in vivo studies.
- Analysis of data on intestinal barrier components (physical, chemical, immunological, microbial).
- Focus on deoxynivalenol, aflatoxins, and ochratoxin A.
Main Results:
- Mycotoxins compromise intestinal integrity, thin mucus layers, imbalance inflammatory factors, and disrupt bacterial homeostasis.
- Deoxynivalenol is a key mycotoxin causing intestinal dysfunction.
- Mycotoxin exposure can contribute to chronic intestinal diseases.
Conclusions:
- Mycotoxins significantly impair intestinal barrier functions through multiple mechanisms.
- Understanding these effects is crucial for developing strategies against mycotoxicosis.
- Combined mycotoxin effects warrant further investigation.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Mucosal Barrier of the Stomach
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Fungal Phylum Microsporidia
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

